Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Julie Smith currently holds 28,957 shares of Stoke Therapeutics, Inc. (STOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julie Smith has been a net seller of STOK stock. They have purchased $0 and sold $576.2K worth of shares.
Julie Smith's most recent insider trade was on May 27, 2026, when they sold 8,367 shares at $0.00 per share.
Julie Smith serves as Executive at Stoke Therapeutics, Inc. (STOK). They have executed 13 insider transactions totaling $576.2K over their tenure at the company.
Julie Smith holds the position of Executive at Stoke Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Julie Smith has shown a selling trading pattern, with $0 in total purchases and $576.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Julie Smith was on Oct 25, 2016, when they sold $577.6K worth of RPTP shares. This transaction involved 64,179 shares at $9.00 per share.
Julie Smith currently owns 28,957 shares of Stoke Therapeutics, Inc. (STOK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Julie Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Julie Smith has 13 Form 4 filings on record as an insider at Stoke Therapeutics, Inc..
Set alerts for Julie Smith and 40,000+ other insiders.